Renibus Therapeutics, Inc.

Quick facts

Phase 3 pipeline

• RBT-1 · Cardiovascular
  RBT-1 is a small molecule that targets the renin-angiotensin system to treat hypertension.

Phase 2 pipeline

• Low Dose RBT-1 · Cardiovascular
  Low Dose RBT-1 is a renin-angiotensin system inhibitor.

Phase 1 pipeline

• RBT-3

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Renibus Therapeutics, Inc. portfolio CI brief
• Renibus Therapeutics, Inc. pipeline updates RSS